NEW YORK (GenomeWeb News) – Cancer genomics firm Foundation Medicine has filed to go public, with a target goal of raising as much as $86.3 million.

The Cambridge, Mass.-based firm has not yet priced its shares or said how many shares it plans to offer in its initial public offering. It plans to list on the Nasdaq under ticker symbol "FMI".

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.